XML 42 R29.htm IDEA: XBRL DOCUMENT
v3.21.2

Revenue (Tables) | 9 Months Ended
--- | ---
Jun. 26, 2021
Revenue from Contract with Customer [Abstract] |
Disaggregation of Revenue | The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:
|  | Three Months Ended June 26, 2021 |  | Three Months Ended June 27, 2020
Business (in millions) | United States | International | Total |  | United States | International | Total
Diagnostics: |  |  |  |  |  |  |
| Cytology & Perinatal | $ | 73.9 |  | $ | 42.0 |  | $ | 115.9 |  |  | $ | 40.3 |  | $ | 23.8 |  | $ | 64.1 |
| Molecular Diagnostics | 270.1 |  | 266.3 |  | 536.4 |  |  | 391.0 |  | 69.3 |  | 460.3 |
| Blood Screening | 13.2 |  | — |  | 13.2 |  |  | 7.8 |  | — |  | 7.8 |
Total | $ | 357.2 |  | $ | 308.3 |  | $ | 665.5 |  |  | $ | 439.1 |  | $ | 93.1 |  | $ | 532.2 |
Breast Health: |  |  |  |  |  |  |
| Breast Imaging | $ | 218.4 |  | $ | 61.9 |  | $ | 280.3 |  |  | $ | 145.6 |  | $ | 47.6 |  | $ | 193.2 |
| Interventional Breast Solutions | 54.8 |  | 13.9 |  | 68.7 |  |  | 25.0 |  | 5.8 |  | 30.8 |
Total | $ | 273.2 |  | $ | 75.8 |  | $ | 349.0 |  |  | $ | 170.6 |  | $ | 53.4 |  | $ | 224.0 |
GYN Surgical | $ | 103.9 |  | $ | 24.0 |  | $ | 127.9 |  |  | $ | 42.1 |  | $ | 9.4 |  | $ | 51.5 |
Skeletal Health | $ | 15.6 |  | $ | 10.3 |  | $ | 25.9 |  |  | $ | 9.0 |  | $ | 6.2 |  | $ | 15.2 |
|  | $ | 749.9 |  | $ | 418.4 |  | $ | 1,168.3 |  |  | $ | 660.8 |  | $ | 162.1 |  | $ | 822.9 |
|  | Nine Months Ended June 26, 2021 |  | Nine Months Ended June 27, 2020
Business (in millions) | United States | International | Total |  | United States | International | Total
Diagnostics: |  |  |  |  |  |  |
| Cytology & Perinatal | $ | 230.8 |  | $ | 127.1 |  | $ | 357.9 |  |  | $ | 191.1 |  | $ | 107.6 |  | $ | 298.7 |
| Molecular Diagnostics | 1,561.7 |  | 905.3 |  | 2,467.0 |  |  | 683.0 |  | 146.5 |  | 829.5 |
| Blood Screening | 33.3 |  | — |  | 33.3 |  |  | 35.0 |  | — |  | 35.0 |
Total | $ | 1,825.8 |  | $ | 1,032.4 |  | $ | 2,858.2 |  |  | $ | 909.1 |  | $ | 254.1 |  | $ | 1,163.2 |
Breast Health: |  |  |  |  |  |  |
| Breast Imaging | $ | 619.5 |  | $ | 198.3 |  | $ | 817.8 |  |  | $ | 541.1 |  | $ | 177.1 |  | $ | 718.2 |
| Interventional Breast Solutions | 164.9 |  | 35.3 |  | 200.2 |  |  | 120.4 |  | 24.2 |  | 144.6 |
Total | $ | 784.4 |  | $ | 233.6 |  | $ | 1,018.0 |  |  | $ | 661.5 |  | $ | 201.3 |  | $ | 862.8 |
GYN Surgical | $ | 296.8 |  | $ | 69.4 |  | $ | 366.2 |  |  | $ | 227.6 |  | $ | 48.3 |  | $ | 275.9 |
Medical Aesthetics | $ | — |  | $ | — |  | $ | — |  |  | $ | 30.9 |  | $ | 34.4 |  | $ | 65.3 |
Skeletal Health | $ | 44.7 |  | $ | 28.6 |  | $ | 73.3 |  |  | $ | 39.4 |  | $ | 22.9 |  | $ | 62.3 |
|  | $ | 2,951.7 |  | $ | 1,364.0 |  | $ | 4,315.7 |  |  | $ | 1,868.5 |  | $ | 561.0 |  | $ | 2,429.5 |
|  | Three Months Ended |  | Nine Months Ended
Geographic Regions (in millions) |  | June 26, 2021 | June 27, 2020 |  | June 26, 2021 | June 27, 2020
United States |  | $ | 749.9 |  | $ | 660.8 |  |  | $ | 2,951.7 |  | $ | 1,868.5 |
Europe |  | 289.0 |  | 101.7 |  |  | 963.9 |  | 322.9 |
Asia-Pacific |  | 89.6 |  | 43.7 |  |  | 268.1 |  | 155.5 |
Rest of World |  | 39.8 |  | 16.7 |  |  | 132.0 |  | 82.6 |
|  | $ | 1,168.3 |  | $ | 822.9 |  |  | $ | 4,315.7 |  | $ | 2,429.5 |
The following table provides revenue recognized by source:
|  | Three Months Ended |  | Nine Months Ended
Revenue by type (in millions) |  | June 26, 2021 | June 27, 2020 |  | June 26, 2021 | June 27, 2020
Disposables |  | $ | 797.7 |  | $ | 588.1 |  |  | $ | 3,239.2 |  | $ | 1,511.4 |
Capital equipment, components and software |  | 197.5 |  | 113.5 |  |  | 590.2 |  | 513.1 |
Service |  | 158.4 |  | 116.4 |  |  | 437.2 |  | 388.6 |
Other |  | 14.7 |  | 4.9 |  |  | 49.1 |  | 16.4 |
|  | $ | 1,168.3 |  | $ | 822.9 |  |  | $ | 4,315.7 |  | $ | 2,429.5 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration